do-me/EUR-LEX huggingface dataset:
Prior notification of a concentration (Case M.9605 — DAK Americas/Lotte Chemical UK) Candidate case for simplified procedure (Text with EEA relevance) 2019/C 382/09
Date: 2019-11-11
Institutions: Directorate-General for Competition, European Commission
Subjects: economic concentration, information technology industry, merger control, motor vehicle industry, plastics industry, refrigeration industry, telecommunications industry








C_2019382EN.01002501.xml










11.11.2019   


EN


Official Journal of the European Union


C 382/25






Prior notification of a concentration
(Case M.9605 — DAK Americas/Lotte Chemical UK)
Candidate case for simplified procedure
(Text with EEA relevance)
(2019/C 382/09)

1.   
On 4 November 2019, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1).
This notification concerns the following undertakings:






—


DAK Americas Exterior, S.L. (‘DAK Americas’, Spain), ultimately controlled by ALFA, S.A.B. de C.V. (‘ALFA Group’, Mexico),










—


Lotte Chemical UK Limited (‘Lotte UK’, United Kingdom),




The ALFA Group, though its subsidiary DAK Americas, acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of Lotte UK.
The concentration is accomplished by way of purchase of shares.


2.   
The business activities of the undertakings concerned are:






—


DAK Americas is part of the ALFA Group, an industrial conglomerate headquartered in Mexico, active in a range of areas including polyester, plastics and chemicals, aluminium auto components, refrigerated foods, and IT & telecoms,










—


Lotte UK is active in the manufacture of polyethylene terephthalate (PET) resin.






3.   
On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.
Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.


4.   
The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:
M.9605 — DAK Americas/Lotte Chemical UK
Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:
Email: COMP-MERGER-REGISTRY@ec.europa.eu
Fax +32 22964301
Postal address:





European Commission




Directorate-General for Competition




Merger Registry




1049 Bruxelles/Brussel




BELGIQUE/BELGIË







(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2)  OJ C 366, 14.12.2013, p. 5.
Euro exchange ratesSource: reference exchange rate published by the ECB. 8 November 20192019/C 382/04
Date: 2019-11-11
Institutions: European Commission
Subjects: euro, exchange rate, money








C_2019382EN.01000501.xml










11.11.2019   


EN


Official Journal of the European Union


C 382/5






Euro exchange rates (1)

8 November 2019
(2019/C 382/04)

1 euro =











 


Currency


Exchange rate




USD


US dollar


1,1034 




JPY


Japanese yen


120,72 




DKK


Danish krone


7,4727 




GBP


Pound sterling


0,86158 




SEK


Swedish krona


10,7025 




CHF


Swiss franc


1,0991 




ISK


Iceland króna


137,70 




NOK


Norwegian krone


10,0893 




BGN


Bulgarian lev


1,9558 




CZK


Czech koruna


25,486 




HUF


Hungarian forint


333,37 




PLN


Polish zloty


4,2610 




RON


Romanian leu


4,7638 




TRY


Turkish lira


6,3513 




AUD


Australian dollar


1,6065 




CAD


Canadian dollar


1,4561 




HKD


Hong Kong dollar


8,6372 




NZD


New Zealand dollar


1,7426 




SGD


Singapore dollar


1,5002 




KRW


South Korean won


1 276,66 




ZAR


South African rand


16,3121 




CNY


Chinese yuan renminbi


7,7115 




HRK


Croatian kuna


7,4345 




IDR


Indonesian rupiah


15 463,05 




MYR


Malaysian ringgit


4,5609 




PHP


Philippine peso


55,809 




RUB


Russian rouble


70,4653 




THB


Thai baht


33,527 




BRL


Brazilian real


4,5583 




MXN


Mexican peso


21,1383 




INR


Indian rupee


78,6520 






(1)  Source: reference exchange rate published by the ECB.
Case C-823/19 P: Appeal brought on 11 November 2019 by ruwido austria GmbH against the order of the General Court (Sixth Chamber) delivered on 11 September 2019 in Case T-649/18 ruwido austria GmbH v European Union Intellectual Property Office
Date: 2019-11-11
Institutions: Court of Justice
Subjects: EU trade mark, computer equipment, provision of services, registered trade mark, software, trade-mark law








C_2020103EN.01000803.xml










30.3.2020   


EN


Official Journal of the European Union


C 103/8






Appeal brought on 11 November 2019 by ruwido austria GmbH against the order of the General Court (Sixth Chamber) delivered on 11 September 2019 in Case T-649/18 ruwido austria GmbH v European Union Intellectual Property Office
(Case C-823/19 P)
(2020/C 103/12)
Language of the case: German

Parties


Appellant: ruwido austria GmbH (represented by: A. Ginzburg, lawyer)

Other party to the proceedings: European Union Intellectual Property Office
By order of 13 February 2020, the Court of Justice of the European Union (Chamber determining whether appeals may proceed) did not allow the appeal to proceed and ordered the appellant to pay its own costs.
Case T-525/19 RII: Order of the President of the General Court of 11 November 2019 — Intering and Others v Commission (Interim measures — Programme entitled ‘EU Support to clean air in Kosovo’ — Tendering procedure EuropeAid/140043/DH/WKS/XK — Decision rejecting the suspension of operation of the decision to exclude an applicant from the further tendering procedure — New application for interim measures — Article 159 of the Rules of Procedure — Inadmissibility)
Date: 2019-11-11
Institutions: General Court
Subjects: EU aid, Kosovo, admissibility, air quality, atmospheric pollutant, award of contract, pollution control measures, tendering








C_2020027EN.01003501.xml










27.1.2020   


EN


Official Journal of the European Union


C 27/35






Order of the President of the General Court of 11 November 2019 — Intering and Others v Commission
(Case T-525/19 RII)
(Interim measures - Programme entitled ‘EU Support to clean air in Kosovo’ - Tendering procedure EuropeAid/140043/DH/WKS/XK - Decision rejecting the suspension of operation of the decision to exclude an applicant from the further tendering procedure - New application for interim measures - Article 159 of the Rules of Procedure - Inadmissibility)
(2020/C 27/43)
Language of the case: German

Parties


Applicants: Intering Sh.p.k (Obiliq, Kosovo), Steinmüller Engineering GmbH (Gummersbach, Germany), Deling d.o.o. za proizvodnju, promet i usluge (Tuzla, Bosnia and Herzegovina), ZM-Vikom d.o.o. za proizvodnju, konstruckcije i montažu (Šibenik, Croatia) (represented by: R. Spielhofen, lawyer)

Defendant: European Commission (represented by: B. Bertelmann, J. Estrada de Solà and M. Kellerbauer, Agents)

Re:

Application under Article 159 of the Rules of Procedure of the General Court seeking the suspension of operation of the decision of the European Commission of 29 June 2019 on the exclusion of the applicant from the further tendering procedure and its non-inclusion on the short list in connection with a procedure for the award of a contract under a programme entitled ‘EU Support to clean air in Kosovo’ to reduce dust and NOx emissions at TPP Kosovo B, Units B1 and B2 (EuropeAid/140043/DH/WKS/XK).

Operative part of the judgment

The Court:






1)



Dismisses the application for interim measures.











2)



Reserves the costs.
Case T-173/17: Order of the General Court of 11 November 2019 — TestBioTech v Commission
Date: 2019-11-11
Institutions: General Court
Subjects: animal feedingstuffs, consumer information, food safety, foodstuff, genetically modified organism, health control, labelling, market approval, plant health legislation, soya bean








C_2020010EN.01005701.xml










13.1.2020   


EN


Official Journal of the European Union


C 10/57






Order of the General Court of 11 November 2019 — TestBioTech v Commission
(Case T-173/17) (1)

(2020/C 10/67)
Language of the case: English
The President of the Second Chamber has ordered that the case be removed from the register.


(1)  OJ C 161, 22.5.2017.
Non-opposition to a notified concentration (Case M.9570 — Bridgepoint/Latour/Primonial) (Text with EEA relevance) 2019/C 392/02
Date: 2019-11-11
Institutions: Directorate-General for Competition, European Commission
Subjects: consultancy, economic concentration, financial services, investment company, merger control








C_2019392EN.01000201.xml










19.11.2019   


EN


Official Journal of the European Union


C 392/2






Non-opposition to a notified concentration
(Case M.9570 — Bridgepoint/Latour/Primonial)
(Text with EEA relevance)
(2019/C 392/02)
On 11 November 2019, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in French and will be made public after it is cleared of any business secrets it may contain. It will be available:






—


in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,










—


in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32019M9570. EUR-Lex is the online access to European law.






(1)  OJ L 24, 29.1.2004, p. 1.
Case T-792/19: Action brought on 11 November 2019 — Agepha Pharma v EUIPO — Apogepha Arzneimittel (AGEPHA)
Date: 2019-11-11
Institutions: General Court
Subjects: EU trade mark, baby food, dental medicine, dietary product, pharmaceutical product, plant health product, registered trade mark, trade-mark law, veterinary medicinal product








C_2020010EN.01005001.xml










13.1.2020   


EN


Official Journal of the European Union


C 10/50






Action brought on 11 November 2019 — Agepha Pharma v EUIPO — Apogepha Arzneimittel (AGEPHA)
(Case T-792/19)
(2020/C 10/61)
Language in which the application was lodged: German

Parties


Applicant: Agepha Pharma s. r. o. (Senec, Slovakia) (represented by: D. Göbel, lawyer)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Apogepha Arzneimittel GmbH (Dresden, Germany)

Details of the proceedings before EUIPO


Applicant for the trade mark at issue: Applicant

Trade mark at issue: Application for EU word mark AGEPHA — EU trade mark application No 7 007 909

Procedure before EUIPO: Opposition proceedings

Contested decision: Decision of the Second Board of Appeal of EUIPO of 26 August 2019 in Case R 386/2019-2

Form of order sought

The applicant claims that the Court should:






—


vary the contested decision and reject the opposition;










—


in the alternative, annul the contested decision;










—


order EUIPO and the other party to pay the costs incurred in the proceedings before the Second Board of Appeal and in the present proceedings.





Pleas in law







—


infringement of Article 42(2) of Council Regulation (EC) No 207/2009;










—


infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.
Non-opposition to a notified concentration (Case M.9509 — Warburg Pincus/CDPQ/Allied Universal) (Text with EEA relevance) 2019/C 392/03
Date: 2019-11-11
Institutions: Directorate-General for Competition, European Commission
Subjects: economic concentration, investment company, merger control, security services








C_2019392EN.01000301.xml










19.11.2019   


EN


Official Journal of the European Union


C 392/3






Non-opposition to a notified concentration
(Case M.9509 — Warburg Pincus/CDPQ/Allied Universal)
(Text with EEA relevance)
(2019/C 392/03)
On 11 November 2019, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:






—


in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,










—


in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32019M9509. EUR-Lex is the online access to European law.






(1)  OJ L 24, 29.1.2004, p. 1.